Literature DB >> 4047545

Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix.

P Gauthier, I Gore, H M Shingleton, S J Soong, J W Orr, K D Hatch.   

Abstract

This study was undertaken to identify histopathologic risk factors in 100 women with stage IB squamous cell carcinoma of the cervix treated surgically. Histologic factors included maximum depth of stromal invasion, presence of lymph-vascular invasion, mitotic activity, nature of the tumor-stromal borders, plasma cell-lymphocyte stromal response, histologic grade, and metastases to regional lymph nodes. Using a multifactorial analysis, the maximum depth of stromal invasion was found to be the most important prognostic indicator (P less than .0001). The depth of invasion also correlated significantly with the presence of nodal metastases (P less than .0001), lymph-vascular space invasion (P = .0003), and "spreading" versus "pushing" borders (P = .0315). The number of mitoses, grade of tumor, or plasma cell-lymphocyte stromal response did not correlate significantly with depth of stromal invasion. Lymph-vascular involvement, although present in 59% of the patients, did not significantly affect survival. Depth of stromal invasion and lesion diameter were combined to constitute three risk groups: Patients with small size cervical tumors (less than 2 cm), regardless of depth of stromal invasion, as well as patients with intermediate size lesions (2.1 to 3 cm) with stromal invasion less than or equal to 1.5 cm, constituted a low-risk group; the intermediate-risk group was comprised of those patients with cervical lesions between 2.1 and 3 cm in size and deep stromal invasion (greater than 1.5 cm), as well as those patients with large cervical lesions (greater than 3.0 cm) and stromal invasion less than or equal to 1.5 cm.2+ (greater than 3 cm) and deep stromal invasion (greater than 1.5 cm).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4047545

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

Review 2.  The role of radical hysterectomy and neoadjuvant chemotherapy in carcinoma of the cervix.

Authors:  David H Moore
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

3.  Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.

Authors:  Xue-lian Du; Xiu-gui Sheng; Tao Jiang; Hao Yu; Yu-feng Yan; Rong Gao; Chun-hua Lu; Qing-shui Li
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

4.  Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.

Authors:  C A Chen; T M Chen; C C Wu; C F Chang; C Y Hsieh
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  Clinical significance of mucin production in post-irradiated cervical carcinoma.

Authors:  N Y Cheung; R J Collins; H Y Ngan; L C Wong; H K Ma
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

6.  Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics.

Authors:  W Wang; H-L Jia; J-M Huang; Y-C Liang; H Tan; H-Z Geng; L-Y Guo; S-Z Yao
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.